Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 200 participants.

Also called NCT03246594

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 200 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03246594
Other papers using this trial's data
  • Oesophageal Probe Evaluation in Radiofrequency Ablation of Atrial Fibrillation (OPERA): results from a prospective randomized trial Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2020-10-01 DOI, PubMed 32820324

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03246594. Randomized; single masking; primary purpose treatment. Start 2017-07-03 (actual); primary completion 2019-04-25 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Oesophageal Probe Evaluation in RF Ablation of Atrial Fibrillation
Acronym
OPERA
Intervention (Device)
Placement of oesophageal probe for temperature measurement
Intervention (Device)
Power limitation of RF generator
Lead sponsor
Heart Center Leipzig - University Hospital (class: other)

Record details

Record id
cardio:ct-nct03246594
Content hash
d37f5d70a7327d9645450ac57705ea4aca7c4fa969edcc887f809bf329a909eb